Polaris Venture Partners Entrepreneurs' Fund V, L.P.'s Net Worth

$177 Million

Who is Polaris Venture Partners Entrepreneurs' Fund V, L.P.?

Polaris Venture Partners Entrepreneurs' Fund V, L.P. has an estimated net worth of $177 Million. This is based on reported shares across multiple companies, which include Phreesia, Inc., BIND Therapeutics, Inc, Adagio Therapeutics, Inc., Cardlytics, Inc., Pulmatrix, Inc., OCULAR THERAPEUTIX, INC, FATE THERAPEUTICS INC, TREVENA INC, GENOCEA BIOSCIENCES, INC., SELECTA BIOSCIENCES INC, Cerulean Pharma Inc., Lyra Therapeutics, Inc., Kala Pharmaceuticals, Inc., T2 Biosystems, Inc., aTYR PHARMA INC, Arsanis, Inc., and INTERNET BRANDS, INC..

SEC CIK

Polaris Venture Partners Entrepreneurs' Fund V, L.P.'s CIK is 0001439587

Past Insider Trading and Trends

2018 was Polaris Venture Partners Entrepreneurs' Fund V, L.P.'s most active year for acquiring shares with 54 total transactions. Polaris Venture Partners Entrepreneurs' Fund V, L.P.'s most active month to acquire stocks was the month of January. 2015 was Polaris Venture Partners Entrepreneurs' Fund V, L.P.'s most active year for disposing of shares, totalling 128 transactions. Polaris Venture Partners Entrepreneurs' Fund V, L.P.'s most active month to dispose stocks was the month of June. 2014 saw Polaris Venture Partners Entrepreneurs' Fund V, L.P. paying a total of $16,944,749.00 for 14,682,469 shares, this is the most they've acquired in one year. In 2015 Polaris Venture Partners Entrepreneurs' Fund V, L.P. cashed out on 15,642,290 shares for a total of $21,694,891.32, their largest year based on trade value.